# Calyxia S.A.S

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/calyxia-s-a-s

- Industry: Chemicals
- Headquarters: France
- Website: www.calyxia.com
- Total disclosed funding: $53M
- Latest round: Series B (Sep 5, 2024)
- Investors on record: 3

## About

Based in France, and founded in 2015, Calyxia S.A.S is a certified B Corp that operates as an industrial B2B clean technology company. The company was founded by its CEO, Jamie Walters, Damien Demoulin, Jerome Bibette, and David Weitz. In September 2024, Calyxia S.A.S. raised USD 35 million in Series B funding led by Lombard Odier, Bpifrance Investissement, and Astanor Ventures.

Calyxia designs and manufactures microcapsules and microparticles for a variety of industries, including agriculture, home care, and advanced materials. The company’s product line includes Calyxia NaturaCaps, which are biodegradable and eco-engineered microcapsules for agricultural ingredients; Calycare® and Calybeauty, which are microplastic-free microcapsules and microparticles for home and personal care products; Calyshield® microcapsules; Catalyx® microcapsules; ActivOptix® microcapsules; and many more.

The company plans to utilize the September 2024 funding raised to implement its innovative manufacturing technology on a global scale, attain profitability, and position itself as the market leader in an industry surpassing $10 billion by 2030.

## Funding rounds

- Series B, Sep 5, 2024, $35M — Bpifrance Investissement, Lombard Odier, Astanor Ventures
- Series A, Sep 21, 2021, $18M — Astanor Ventures

## Investors

- Astanor Ventures (https://capitalatlas.ai/funds/astanor-ventures) — Series A, Series B
- Bpifrance Investissement (https://capitalatlas.ai/funds/bpifrance-investissement) — Series B
- Lombard Odier (https://capitalatlas.ai/funds/lombard-odier) — Series B